Research and Innovation Showcase 2025

Tuesday, April 1st, 2025
1:30 PM to 6:30 PM ET

Lohrfink Auditorium, Rafik B. Hariri Building, Georgetown University, Washington, DC 20057

The Office of Technology Commercialization, in collaboration with Georgetown Entrepreneurship Initiative, is excited to announce the first Research and Innovation Showcase event. This half-day celebration will highlight discoveries, celebrate innovation, feature new ventures, and connect academia with industry and investors. The event includes research presentations, an industry panel discussion, and a venture fair presenting new, exciting entrepreneurial companies and teams from the Georgetown community.

Event Highlights (Please check back for updated agenda):

Research Presentations (1.30 PM-3.00 PM EST)

Dr. Louis Weiner delivering a Lecture

Explore the latest breakthroughs across key research areas in Life Sciences, MedTech, Physical Sciences, AI, and Software through through a short presentation from leading Georgetown researchers.

Industry Panel Discussion (3.00 PM- 4.00 PM)

OTC Panel Discussion 2015

Hear from industry leaders on how cutting-edge university research transitions into real-world solutions.

Image : Zachary Cooper, PhD

Zachary Cooper, PhD

Senior Director, External R&D and Innovation, Oncology R&D, AstraZeneca

Dr. Zachary Cooper is a Senior Director of External R&D at AstraZeneca. As part of AstraZeneca for 9 years, Zachary has brought robust expertise in tumor immunology, the tumor microenvironment, and biomarker analysis in clinical samples/trials.

Dr. Cooper has initiated and managed external collaborations and alliances at AstraZeneca, influencing the portfolio’s strategy for various therapeutic areas including immuno-oncology, cell therapy and antibody drug-conjugates (ADCs). He previously led translational strategy for a variety of first time in human trials for immuno-oncology including the adenosine pathway (CD73 and CD39) and ADCs targeting B7H4.

Prior to AstraZeneca, he served as an Assistant Professor at MD Anderson Cancer Center in Surgical Oncology and Genomic Medicine, where he focused on understanding response and resistance to targeted therapies and immunotherapy for melanoma. Dr. Cooper obtained his PhD in Molecular Medicine from the University of Maryland, as well as Postdoctoral Fellowships at Brown University and Harvard Medical School/Massachusetts General Hospital. Dr. Cooper has authored over 80 manuscripts including those in Science, Nature, Cell, Nature Genetics, Lancet Oncology, Cancer Discovery, Cancer Cell, and others.

Alex Cameron, MS, MBA

Global Vice President and Head of Siemens Solutions

Alex Cameron is the Global Vice President and Head of Siemens Solutions at Siemens Healthineers, leading global marketing across a comprehensive portfolio of diagnostic solutions, including analyzers, assays, informatics, and automation. His focus is on delivering integrated value to healthcare providers worldwide.

Previously, Alex served as Senior Director and Business Leader for Lab Automation at BD Integrated Diagnostic Solutions, where he oversaw marketing, operations, R&D, regulatory affairs, HR, and finance. His diagnostics background also includes leading Zimmer Biomet’s diagnostics business, where he was instrumental in product launches, M&A, and corporate strategy.

Actively engaged in his community, Alex serves on the Young Professionals Board of First Tee of Baltimore and mentors with Johns Hopkins Technology Ventures. He has also served on the board of the Maryland Tech Council.

Alex holds an MBA from The Wharton School, an MS from Johns Hopkins University, and a BS from Dickinson College. He resides with his family in the Baltimore area.

Adam Deer

Industry Executive, Rapid Innovation for Education and Research, Google Cloud

Adam is a passionate advocate for the transformative power of technology in education. With an 18-year tenure at Google spanning diverse roles, Adam has spent the last 10 years dedicated to building cutting-edge technology solutions for the education industry. His expertise lies in leveraging Generative AI to address critical challenges in K-12 and higher education, improving teaching and learning experiences, and empowering research computing. 

Georgetown Venture Fair (4.00 PM-5.00 PM)

2024 Innovation Award reception

A fast-paced venture fair featuring nine pitches from faculty, students, and alumni-led startups working on disruptive technologies. The event will attract investors, venture capitalists, angel investors, and corporate innovation teams eager to engage with emerging ventures.

Presenting Ventures

Faculty Startups

Peter Frantz

Peter Frantz, COO Frantz Viral Therapeutics

Frantz Viral Therapeutics (FVT) is working to change the landscape of care for human papillomavirus (HPV)-induced pre-cancers (intraepithelial neoplasia).   There are no approved non-surgical therapies to treat these indications, which affect nearly 1 million people in the US each year alone.  The treatment was discovered by Dr. Richard Schlegel and others at Georgetown, and FVT is led by two alumni.  FVT is well positioned to be the first to market in this space with a self-administered topical formulation of artesunate.  Phase 1/2A studies were completed with excellent safety data and promising efficacy results.  Three randomized Phase 2B studies are currently enrolling in cervical, vulvar, and anal indications.

Frantz Viral Therapeutics
Chris Hoyt

Chris Hoyt, CEO KeifeRx

KeifeRx is a spin-out from Georgetown University founded in 2019 focused on developing disease-modifying treatments for dementia.  We have exclusively licensed a pipeline of potent kinase inhibitors developed in the lab of Dr. Moussa that have been shown in clinical trials to slow dementia at twice the rates of existing drugs in half the time without negative side effects.   This translates directly into extended quality of life and reduced suffering for patients.

KeifeRx

“TeloHealthDX”

  • Hilda
  • Provision Surgical
  • Darsaber Labs

  • Nyxara
  • Torev Motors
  • Neuro Ascend

This event is a must-attend for researchers, entrepreneurs, investors, and industry partners eager to explore collaborations, funding opportunities, and commercialization pathways for innovative Georgetown technologies.

Networking reception (5.00 PM-6.30 PM)

2024 Innovation Awards Networking Highlights

Registration Information:

Please RSVP by March 24th, 2025, to secure your place at this prestigious celebration of innovation. Don’t miss this opportunity to connect with the Georgetown and regional innovation and entrepreneurship community.